Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 3 56-3, 2004, Pages

  Canyon, Sarah J ^a   Dobson, Geoffrey P ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

ATP sensitive K+ channel; Heart; Infarction; Na+ channel; Sudden death

Indexed keywords

ADENOSINE DEAMINASE INHIBITOR; LIDOCAINE; PENTOBARBITAL; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCARDIOGRAM; HEART DEATH; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SUDDEN DEATH;

ADENOSINE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DRUG COMBINATIONS; HEMODYNAMIC PROCESSES; LIDOCAINE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 4143053533     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00273.2004     Document Type: Article

References (68)

1. Alexander JH, Granger CB, Sadowski Z, Aylward PE, White HD, Thompson TD, Califf RM, and Topol EJ. Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb investigators. Am Heart J 137: 799-805, 1999.
2. Barrett TD, Hayes ES, and Walker MJA. Lack of sensitivity for ventricular and ischaemic tissue limites the antiarrhythmic actions of lidocaine, quinidine and felcainide against ischaemia-induced arrhythmias. Eur J Pharmacol 285: 229-238, 1995.
3. Barrett TD, Hayes ES, Yong SL, Zolotoy AB, Abraham S, and Walker MJA. Ischaemia selectivity confers efficacy for suppression of ischaemia-induced arrhythmias in rats. Eur J Pharmacol 398: 365-374, 2000.
4. Belardinelli L and Giles WR. Ionic mechanisms of adenosine action in pacemaker cells from rabbit heart. J Physiol 405: 615-633, 1988.
5. Belardinelli L, Shryock JC, Song Y, Wang D, and Srinivas M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J 9: 359-365, 1995.
6. Billman GE, Englert HC, and Scholkens A. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. II. Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther 286: 1465-1473, 1998.
7. Burton FL and Cobbe SM. Dispersion of ventricular repolarisation and refractory period. Cardiovasc Res 50: 10-23, 2001.
8. 1 adenosine receptor agonist CCPA in the rabbit. Pharmacol Res 35: 51-55, 1997.
9. Coetzee WA, Wells T, and Avkiran M. Antiarrhythmic effects of levcromakalim in the ischemic rate heart: a dual mechanism of action? Eur J Pharmacol 402: 263-274, 2000.
10. De Jonge R, De Jong JW, Keijzer E, and Bradamante S. The role of adenosine in preconditioning. Pharmacol Ther 87: 141-149, 2000.
11. Dobson GP. On being the right size: heart design, mitochondrial efficiency, and lifespan potential. Clin Exp Pharmacol Physioi 30: 590-597, 2003.
12. Dobson GP and Jones MW. Adenosine and lignocaine: a new concept in non-depolarising surgical arrest, protection and preservation. J Thorac Cardiovasc Surg 127: 794-805, 2004.
13. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Supression Trial. N Engl J Med 324: 781-788, 1991.
14. El-Sherif N, Scherlag BJ, Lazzara R, and Hope RR. Re-entry ventricular arrhythmias in the late myocardial period. 4. Mechanism of action of lidocaine. Circulation 56: 395-402, 1977.
15. Ely SW and Berne RM. Protective effects of adenosine in myocardial ischaemia. Circulation 85: 893-904, 1992.
16. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, and Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 101: 593-600, 1981.
17. + channels and myocardial protection. Circ Res 84: 973-979, 1999.
18. 1 selective ligands. Cardiovasc Toxicol 3: 1-18, 2003.
19. Hebbar AK and Hueston WJ. Management of common arrhythmias: part I. Supraventricular arrhythmias. Am Fam Physician 65: 2479-2486, 2002.
20. Hine LK, Laird N, Hewitt P, and Chambers TC. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 149: 2694-2698, 1989.
21. Homeister JW, Hoff PT, Fletcher DD, and Lucchesi BR. Combined adenosine and lidocaine administration limits myocardial reperfusion injury. Circulation 82: 595-608, 1990.
22. Hu K, Huang CS, Jan YN, and Jan LY. ATP-sensitive potassium channel traffic regulation by adenosine and protein kinase C. Neuron 38: 417-432, 2003.
23. Huikuri UV, Castellanaos A, and Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 345: 1473-1482, 2001.
24. Janse MJ. A brief history of sudden cardiac death and its therapy. Pharmacol Ther 100: 89-99, 2003.
25. Janse MJ. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 61: 208-217, 2004.
26. Janse MJ, Opthof T, and Kleber AG. Animal models of cardiac arrhythmias. Cardiovasc Res 39: 165-177, 1998.
27. Janse MJ and Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischaemia and infarction. Physiol Rev 69: 1049-1069, 1989.
28. + loss and arrhythmias in rat hearts-effect of glibenclamide, a sulfonylurea. Circ Res 66: 478-485, 1990.
29. 1 receptors by G proteins in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 259: H820-H826, 1990.
30. Lasley RD, Konyn PJ, Hegge JO, and Mentzer RM. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol Heart Circ Physiol 269: H1460-H1466, 1995.
31. Lasley RD and Mentzer RM. Protective effects of adenosine in the reversibly injured heart. Ann Thorac Surg 60: 843-846, 1995.
32. 1 receptor mediated protection of the globally ischemic rat heart. J Mol Cell Cardial 22: 39-47, 1990.
33. Lee HT, LaFaro RJ, and Reed GE. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg 10: 665-676, 1995.
34. Lerman BB, Belardinelli L. Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation 83: 1499-1509, 1991.
35. 1 agonist (CVT-510) on atrioventricular nodal conduction in humans. J Cardiovasc Pharmacol 6: 237-245, 2001.
36. Li GR and Ferrier GR. Effects of lidocaine on reperfusion arrhythmias and electrophysiological properties in an isolated ventricular muscle model of ischemia and reperfusion. J Pharmacol Exp Ther 257: 997-1004, 1991.
37. Li GR, Feng J, Shrier A, and Nattel S. Contribution of ATP-sensitive potassium channels to the electrophysiological effects of adenosine in guinea-pig atrial cells. J Physiol 484: 629-642, 1995.
38. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
39. 2+ influx. Eur J Pharmacol 365: 233-239, 1999.
40. MacMahon S, Collins R, Peto R, Koster RW, and Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 260: 1910-1916, 1988.
41. Mubagwa K. Does adenosine protect the heart by acting on the sarcoplasmic reticulum. Cardiovasc Res 53: 286-289, 2002.
42. Nasser FN, Walls JT, Edwards WD, and Harrison CE. Lidocaine-induced reduction in size of experimental myocardial infarction. Am J Cardiol 46: 967-975, 1980.
43. Nattel S. Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs. Cardiovasc Res 37: 567-577, 1998.
44. Nerbonne JM and Guo W. Heterogeneous expression of voltage-gated potassium channels in the heart: roles in normal excitation and arrhythmias. J Cardiovasc Electrophysiol 13: 406-409, 2002.
45. + channels in cardiac tissue. Nature 305: 147-148, 1983.
46. O'Rourke B. Mitochondrial KATP channels in preconditioning. Circ Res 87: 845-855, 2000.
47. Olschewski A, Brau ME, Olschewski H, Hempelmann G, and Vogel W. ATP-dependent potassium channel in rat cardiomyocytes is blocked by lidocaine. Possible impact on the antiarrhythmic action of lidocaine. Circulation 93: 656-659, 1996.
48. Opitz CF, Mitchell GF, Pfeffer MA, and Pfeffer JM. Arrhythmias and death after coronary artery occlusion in the rat. Circulation 92: 253-261, 1995.
49. Pelleg A. Proarrhythmic effects of adenosine: one decade of clinical data. Am J Therap 9: 141-147, 2002.
50. Ravingerova T, Slezak J, Tribulova N, Dzurba A, Uhrik B, and Ziegelhoffer A. Free oxygen radicals contribute to high incidence of reperfusion-induced arrhythmias in isolated rat heart. Life Sci 65: 1927-1930, 1999.
51. Roden DM. Risks and benefits of antiarrhythmic therapy. N Engl J Med 331: 785-791, 1994.
52. + through gap junctions. Circ Res 85: 280-287, 1999.
53. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EEJ, and Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 28: 1328-1428, 1996.
54. Sadowski ZP, Alexander JH, Skrabucha B, Dyduszynski A, Kuch J, Nartowicz E, Swiatecka G, Kong DF, and Granger CB. Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. Am Heart J 137: 792-798, 1999.
55. Schaper W, Bernotat-Danielowski S, Nienaber C, and Shaper J. Collateral circulation. In: The Heart and Cardiovascular System, edited by Fozzard HA, Jennings RB, Haber E, Katz AM, and Morgan HE. New York: Raven, 1986, p. 1427-1460.
56. Tabrizchi R. Effects of adenosine and adenosine analogues on mean circulatory filing pressure and cardiac output in anaesthetised rats. Naunyn Schmiedebergs Arch Pharmacol 356: 69-75, 1997.
57. Tosaki A, Balint S, and Szekeres L. Protective effect of lidocaine against ischemia and reperfusion-induced arrhythmias and shifts of myocardial sodium, potassium and calcium content. J Cardiovasc Pharmacol 12: 621-628, 1988.
58. + during myocardial ischemia: consequences for post-ischemic recovery. J Mol Cell Cardiol 29: 85-96, 1997.
59. Vander Heide RS and Reimer KA. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc Res 31: 711-718, 1996.
60. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61: 481-497, 2004.
61. Vinten-Johansen J, Thourani VH, Ronson JE, Jordan RS, Zhao ZQ, Nakamura M, Velez D, and Guyton RA. Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 68: 1942-8, 1999.
62. Vitola JV, Forman MB, Holsinger JP, Atkinson JB, and Murray JJ. Reduction of myocardial infarct size in rabbits and inhibition of activation of rabbit and human neutrophils by lidocaine. Am Heart J 133: 315-322, 1997.
63. Wainwright CL and Parratt JR. An antiarrhythmic effect of adenosine during myocardial ischemia and reperfusion. Eur J Pharmacol 145: 183-194, 1988.
64. Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DG, Lah MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, and Woodward B. The Lambeth Convention: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 22: 447-455, 1988.
65. Wilbur SL and Marchlinkski FE. Adenosine as an antiarrhythmic agent. Am J Cardiol 79: 30-37, 1997.
66. Wilson RA, Soei LK, Bezstarosti K, Lamers JM, and Verdouw PD. Negative iontropy of lidocaine: possible biochemical mechanisms. Eur Heart J 14: 284-289, 1993.
67. Wilson RF, Wyche K, Christensen BV, Zimmer S, and Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 82: 1595-1606, 1990.
68. Yao Z and Gross GJ. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs: efficacy, time course, and role of KATP channels. Circulation 89: 1229-1236, 1994.